1. Home
  2. WLY vs AMLX Comparison

WLY vs AMLX Comparison

Compare WLY & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Wiley & Sons Inc.

WLY

John Wiley & Sons Inc.

N/A

Current Price

$36.59

Market Cap

1.6B

ML Signal

N/A

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

N/A

Current Price

$14.73

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WLY
AMLX
Founded
1807
2014
Country
United States
United States
Employees
5200
N/A
Industry
Books
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
WLY
AMLX
Price
$36.59
$14.73
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$19.56
AVG Volume (30 Days)
561.0K
800.3K
Earning Date
01-01-0001
06-08-2026
Dividend Yield
3.88%
N/A
EPS Growth
N/A
65.46
EPS
N/A
N/A
Revenue
N/A
$380,786,000.00
Revenue This Year
$0.02
N/A
Revenue Next Year
$2.32
N/A
P/E Ratio
$15.84
N/A
Revenue Growth
N/A
1612.94
52 Week Low
$28.38
$3.11
52 Week High
$45.60
$17.49

Technical Indicators

Market Signals
Indicator
WLY
AMLX
Relative Strength Index (RSI) 74.41 52.98
Support Level $36.18 $13.28
Resistance Level $38.32 $15.41
Average True Range (ATR) 1.15 0.94
MACD 0.84 -0.02
Stochastic Oscillator 90.43 55.57

Price Performance

Historical Comparison
WLY
AMLX

About WLY John Wiley & Sons Inc.

John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Share on Social Networks: